The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment

BACKGROUND: Artemisinin resistance is a major threat to current efforts to eliminate Plasmodium falciparum malaria which rely heavily on the continuing efficacy of artemisinin combination therapy (ACT). It has been suggested that ACT should not be used in mass drug administration (MDA) in areas wher...

Podrobná bibliografie
Hlavní autoři:	Maude, R, Nguon, C, Dondorp, A, White, L, White, N
Médium:	Journal article
Jazyk:	English
Vydáno:	BioMed Central 2014

Podobné jednotky

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
Autor: Mcgready, R, a další
Vydáno: (2003)

Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
Autor: McKeage, K, a další
Vydáno: (2003)

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
Autor: Färnert, A, a další
Vydáno: (2003)

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
Autor: van Vugt, M, a další
Vydáno: (2002)

Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
Autor: Mcgready, R, a další
Vydáno: (2003)

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Autor: Lacy, MD, a další
Vydáno: (2002)

Early treatment failure during treatment of <it>Plasmodium falciparum</it> malaria with atovaquone-proguanil in the Republic of Ivory Coast
Autor: Wurtz Nathalie, a další
Vydáno: (2012-05-01)

Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru
Autor: A. Llanos-Cuentas, a další

Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
Autor: Maude, R, a další
Vydáno: (2012)

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Autor: Ling, J, a další
Vydáno: (2002)

Mutations in the <it>Plasmodium falciparum cytochrome b </it>gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
Autor: Fivelman Quinton L, a další
Vydáno: (2008-11-01)

Absence of an interaction between artesunate and atovaquone--proguanil.
Autor: van Vugt, M, a další
Vydáno: (1999)

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
Autor: Mcgready, R, a další
Vydáno: (2005)

Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil).
Autor: Butcher, G, a další
Vydáno: (2000)

Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
Autor: Jenny Lea Schnyder, a další
Vydáno: (2025-03-01)

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed <it>Plasmodium falciparum </it>isolates from Africa
Autor: Kyle Dennis E, a další
Vydáno: (2006-10-01)

Detection of atovaquone-proguanil resistance conferring mutations in <it>Plasmodium falciparum </it>cytochrome b gene in Luanda, Angola
Autor: Varandas Luís, a další
Vydáno: (2006-04-01)

The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
Autor: Enosse, S, a další
Vydáno: (2000)

<it>In vitro </it>atovaquone/proguanil susceptibility and characterization of the <it>cytochrome b </it>gene of <it>Plasmodium falciparum </it>from different endemic regions of Thailand
Autor: Mungthin Mathirut, a další
Vydáno: (2008-01-01)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.
Autor: Beatrix Huei-Yi Teo, a další
Vydáno: (2015-01-01)

Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
Autor: Gupta, R, a další
Vydáno: (2005)

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
Autor: Laurencie Massamba, a další
Vydáno: (2020-01-01)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
Autor: Staines, H, a další
Vydáno: (2017)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
Autor: Anja Wiegmann, a další
Vydáno: (2022-07-01)

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
Autor: V Nicosia, a další
Vydáno: (2008-09-01)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
Autor: Chiodini, P, a další
Vydáno: (1995)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
Autor: Chotivanich, K, a další
Vydáno: (2012)

Atovaquone-Proguanil: A Promising Therapy for Persistent Relapsing Babesiosis
Autor: Mahum Shahid, a další
Vydáno: (2024-01-01)

A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
Autor: Kathrine R. Tan, a další
Vydáno: (2018-05-01)

The effects of serum lipids on the <it>in vitro</it> activity of lumefantrine and atovaquone against <it>Plasmodium falciparum</it>
Autor: Chotivanich Kesinee, a další
Vydáno: (2012-05-01)

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study
Autor: Brady, O, a další
Vydáno: (2017)

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.
Autor: Miriam K Laufer, a další
Vydáno: (2012-01-01)

OPTIMISING STRATEGIES FOR MALARIA ELIMINATION: PRIMAQUINE, MASS DRUG ADMINISTRATION AND ARTEMISININ RESISTANCECATEGORY: SCIENTIFIC FREE PAPER
Autor: Maude, R, a další
Vydáno: (2011)

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Autor: Krudsood, S, a další
Vydáno: (2005)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
Autor: Ivanovic Jelena, a další
Vydáno: (2011-05-01)

Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil
Autor: JP Dean Goldring, a další
Vydáno: (1999-09-01)

A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by <i>Plasmodium relictum</i> in Snowy Owl (<i>Bubo scandiacus</i>)
Autor: Nicola Pugliese, a další
Vydáno: (2023-11-01)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
Autor: Dondorp, A, a další
Vydáno: (2009)

Estudo comparativo entre uma combinação de atovaquone mais proguanil e um regime de quinino mais tetraciclina no tratamento de malária aguda por Plasmodium falciparum em adultos no Brasil
Autor: Filomena Euridice Carvalho de Alencar
Vydáno: (1999-04-01)

Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies.
Autor: Tripura, R, a další
Vydáno: (2016)